GeneDx Holdings (WGSWW) Capital Leases (2020 - 2021)

GeneDx Holdings (WGSWW) posted quarterly Capital Leases of $18.4 million for Q4 2021, down 11.31% YoY from $20.8 million in Q4 2020, and down 11.31% sequentially from $20.8 million in Q4 2020.

GeneDx Holdings (WGSWW) Capital Leases (2020 - 2021) Analysis & Trends

GeneDx Holdings has disclosed Capital Leases across 2 years of filings, most recently posting $18.4 million for Q4 2021.

  • In Q4 2021, Capital Leases fell 11.31% year-over-year to $18.4 million; the TTM figure through Dec 2021 stood at $18.4 million (down 11.31% YoY), while the FY2021 annual figure was $18.4 million, down 11.31% from the prior year.
  • Capital Leases slipped to $18.4 million in Q4 2021, from $20.8 million in the prior quarter.
  • Over the last five years, Capital Leases for WGSWW reached as high as $20.8 million in Q4 2020 and fell as low as $18.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 GeneDx Holdings - - 68.21 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 18.43 Mn
Dec 31, 2020 20.78 Mn